Chemical Structure : ATR-258
货号: PC-24799Not For Human Use, Lab Use Only.
ATR-258 (Compound 15) is a specific GRK-biased β2 adrenergic receptor (β2AR) agonist with pEC50 of 6.87, increases glucose uptake with low cAMP generation.
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
ATR-258 (Compound 15) is a specific GRK-biased β2 adrenergic receptor (β2AR) agonist with pEC50 of 6.87, increases glucose uptake with low cAMP generation.
ATR-258 induces minimal internalization compared with compounds that stimulate β-arrestin recruitment.
ATR-258 acts as a competitive β1AR antagonist and shows weak partial agonist activity at β3AR at 10 μM, exhibits high selectivity in the glucose uptake assay.
ATR-258 (0.3 or 0.1 mg/kg) by daily oral gavage for 18 days promotes glucose control with reduced side effects in mouse model of diabetes, acting through GRK2 to mediate glucose uptake in skeletal muscle and improve glycemic control.
ATR-258 (10 mg/kg/day) by daily oral gavage improves muscle mass in a rodent model for diabetic muscular atrophy.
分子量 | 212.27 | |
分子式 | C11H17FN2O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
1. Motso A, et al. Cell. 2025 Jun 19:S0092-8674(25)00630-0.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright